Takeda Pharmaceutical
TAK
#491
Rank
HK$368.15 B
Marketcap
HK$110.63
Share price
0.28%
Change (1 day)
5.89%
Change (1 year)

Takeda Pharmaceutical (TAK) - Total debt

Total debt on the balance sheet as of September 2025 : HK$244.20 Billion

According to Takeda Pharmaceutical's latest financial reports the company's total debt is HK$244.20 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Takeda Pharmaceutical - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2025-03-31HK$234.31 B-6.41%
2024-03-31HK$250.36 B-2.95%
2023-03-31HK$257.97 B-7.72%
2022-03-31HK$279.57 B-14.08%
2021-03-31HK$325.39 B-11.4%
2020-03-31HK$367.25 B-9.7%
2019-03-31HK$406.70 B458.91%
2018-03-31HK$72.76 B-9%
2017-03-31HK$79.96 B50.96%
2016-03-31HK$52.97 B12.44%
2015-03-31HK$47.11 B-27.1%
2014-03-31HK$64.62 B34.27%
2013-03-31HK$48.13 B-5.28%
2012-03-31HK$50.81 B2554.7%
2011-03-31HK$1.91 B23.02%
2010-03-31HK$1.55 B0.23%
2009-03-31HK$1.55 B507.19%
2008-03-31HK$0.25 B-66.83%
2007-03-31HK$0.77 B-7.4%
2006-03-31HK$0.83 B-37.87%
2005-03-31HK$1.33 B21.95%
2004-03-31HK$1.09 B32.15%
2003-03-31HK$0.83 B-9.11%
2002-03-31HK$0.91 B-7.73%
2001-03-31HK$0.99 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$356.28 B 45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$198.63 B-18.66%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
HK$473.40 B 93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$249.13 B 2.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
HK$0.88 B-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$5.12 B-97.90%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
HK$424.69 B 73.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$185.64 B-23.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$321.89 B 31.82%๐Ÿ‡บ๐Ÿ‡ธ USA